Sex differences in COVID‐19 symptom severity and trajectories among ambulatory adults.

Background: The ongoing COVID‐19 pandemic has led to hundreds of millions of infections worldwide. Although differences in COVID‐19 hospitalization rates between males and females have been described, many infections in the general population have been mild, and the severity of symptoms during the course of COVID‐19 in non‐hospitalized males and females is not well understood. Methods: We conducted a case‐ascertained study to examine household transmission of SARS‐CoV‐2 infections in Nashville, Tennessee, between April 2020 and April 2021. Among enrolled ambulatory adult participants with laboratory‐confirmed SARS‐CoV‐2 infections, we assessed the presence and severity of symptoms (total, systemic, and respiratory) daily using a symptoms severity questionnaire, from illness onset and throughout the 2‐week follow‐up period. We compared the mean daily symptom severity scores (0–3: none, mild, moderate, and severe) and change in symptoms between males and females using a multivariable linear mixed effects regression model. Results: The analysis included 223 enrolled adults with SARS‐CoV‐2 infection (58% females, mostly white, non‐Hispanic) from 146 households with 2917 total daily symptom reports. The overall mean severity of total symptoms reported over the illness period was 1.04 and 0.90 for females and males, respectively. Mean systemic and respiratory scores were higher for females than for males (p < 0.001). In multivariable analyses, females reported more severe total and systemic symptoms during the illness period compared with males. However, no significant differences in reported respiratory symptoms were observed. Conclusions: Our findings indicate that among ambulatory adults with SARS‐CoV‐2 infections, females reported slightly higher symptom severity during their illness compared with males. [ABSTRACT FROM AUTHOR]